Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of OAS3 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of OAS3 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of OAS3 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of OAS3 mRNA | increases expression | 19619570
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of OAS3 mRNA | increases expression | 19155303
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of OAS3 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of OAS3 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of OAS3 mRNA | increases expression | 20106945
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS3 mRNA | affects cotreatment|increases expression | 20370541
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 11752688 14514962 15322242 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.24 | 9612607 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.81 | 19861407 14630087 17289903 16675129 17018787 12948864 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.81 | 19059307 20544844 20859285 18855134 16273361 18815881 21138602 19011961 18425577 17893378 17242785 20135344 19103187 18351453 19410462 16818667 19084267 19066611 19487384 15565566 18984771 19189210 20005174 19155303 21152245 19244106 19200415 19221464 20390343 18997820 17261762 19115204 15668708 18821012 17440819 19142967 16873071 20065188 19288272 19189212 19289846 16202921 17049068 18629630 11161223 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.81 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.93 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.10 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.10 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.27 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.27 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 15340226 12621046 15668235 16354765 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.81 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.81 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
9.01 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
9.01 | 15040536 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.92 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.04 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
8.04 | 20544844 16202921 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.17 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.17 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
15.17 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.91 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.91 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 11294989 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.06 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.55 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.63 | 20032539 11141242 11698656 17358032 11363243 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.27 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16354765 18606429 8697196 16959395 15340226 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.28 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.28 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.37 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.37 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.16 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.49 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.49 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
20.10 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.10 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
20.10 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
20.10 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.74 | 20370541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.59 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.59 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.59 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.72 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.62 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.62 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
3.62 | 18800350 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.61 | 16891317 11408345 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.61 | 11731420 19196722 14580682 16827153 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
14.45 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
14.45 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.36 | 17358032 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.52 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.65 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.19 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.77 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.77 | 14600291 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.29 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11896295 11222880 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
6.02 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.02 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.81 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.21 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.45 | 16712894 8653321 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.18 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |